arthritis advocacy news and regulatory letters

Advocacy News & Regulatory Letters

February 20, 2018

Proposed Short-Term Insurance Plans Could Leave Patients with Fewer Protections, Inadequate Coverage

On February 20, the Arthritis Foundation joined 16 patient and consumer groups to issue a statement on a proposed regulation released today by the federal Departments of Labor, Treasury, and Health and Human Services, which would expand the use of "short-term limited duration" insurance plans. The Arthritis Foundation is concerned these types of plans could exclude coverage for certain health care services, and allow insurers to charge individuals with a pre-existing condition higher rates. Read the statement here.

February 12, 2018

CDC Arthritis Coalition Statement on the President’s Fiscal Year 2019 Budget Request

On February 12, the president released the administration’s official budget request for fiscal year 2019. The budget would make cuts to the Chronic Disease Division at the Centers for Disease Control and Prevention (CDC). The division houses the CDC Arthritis Program, the only federal program dedicated solely to arthritis. Read our coalition statement here.

February 9, 2018

Arthritis Foundation Praises Budget Deal, Permanent Repeal of Therapy Caps

Early Friday morning, Congress passed a significant bipartisan budget agreement that would fund many health care priorities important to the arthritis community, raise the budget caps for discretionary spending, and bring Congress closer to closing out work on the fiscal year 2018 appropriations process. Read our statement here. Do you want to learn more about the bipartisan budget agreement and what it means for the arthritis community? Click here to read our FAQ.

February 5, 2018

Arthritis Foundation Comments on Arizona's Proposed Medicaid Waiver

On February 5, the Arthritis Foundation joined a dozen patient organizations to submit comments to the federal Department of Health and Human Services (HHS) expressing concern about the cost containment proposals in the state of Arizona's Medicaid waiver application. The waiver would impose work requirements and place limits on how long Medicaid patients can receive benefits under the program. Our letter follows similar comments submitted to HHS about waiver applications from the states of Kansas and New Mexico. Read the letter here.

January 30, 2018

Arthritis Foundation Comments on Proposed Medicaid Waiver from New Mexico

On January 30, the Arthritis Foundation joined eight patient organizations to submit comments to the federal Department of Health and Human Services expressing concern about some of the policy proposals in the state of New Mexico's Medicaid waiver application. While the Arthritis Foundation shares the goals outlined in the application - such as proposals that would enhance the health of patients with arthritis through coordinated care - new cost sharing and eligibility requirements could pose significant access barriers for patients on Medicaid. Read the letter here.

January 26, 2018

Arthritis Foundation Comments on Proposed Medicaid Waiver from Kansas

On January 26, the Arthritis Foundation joined several other patient organizations to oppose aspects of a proposed Medicaid waiver from the state of Kansas by sending a letter to the federal Department of Health and Human Services. The Kansas waiver would impose work requirements and place time limits on how long Medicaid patients can receive benefits under the program. Arthritis is the leading cause of work-related disability in the United States and these types of proposals can create barriers to accessing or maintaining health care coverage. Read the letter here.

January 25, 2018

Arthritis Foundation Comments on Request for Information to Barriers and Competition

On January 25, the Arthritis Foundation submitted comments in response to a request for information from the Department of Health and Human Services regarding choice and competition in Medicare, Medicaid, and the marketplaces. The comments highlighted concerns about the direction of the health care regulations, and the need to preserve important patient protections under current law, and the potential for erosion of network adequacy standards. Read the letter here.

January 19, 2018

Arthritis Foundation Joins 31 Organizations to Urge CMS to Suspend Application of Therapy Cap Policy

On January 19, the Arthritis Foundation joined dozens of organizations calling for the Centers for Medicare and Medicaid Services (CMS) to suspend the application of the Medicare therapy cap policy. Beginning on January 1, 2018, there is a limit on the amount of outpatient rehabilitation services that the Medicare program will cover. Physical and occupational therapy plays an important role in the treatment of arthritis by improving mobility and restoring the use of affected joints, increasing strength to support the joints, and maintaining fitness and the ability to perform daily activities. Read the letter here.

January 17, 2018

Arthritis Foundation Applauds Consensus Statement on Improving Prior Authorization Process

On January 17, six organizations representing health care providers and health plans released a consensus statement to find opportunities to improve prior authorization programs. The Arthritis Foundation applauds the consensus statement, which follows a separate publication of 21 prior authorization and utilization management reform principles in 2017. The Arthritis Foundation was the only patient organization to participate in the development of these principles last year. The principles strongly urge health plans and benefit managers to apply the principles to utilization management programs for pharmacy and medical benefits. Read the principles here.

January 16, 2018

Arthritis Foundation Signs Coalition Letter Addressing Medicare Advantage and Part D Proposed Rule

On January 16, the Arthritis Foundation joined nearly three dozen organizations from MAPRx, a national coalition of beneficiary, caregiver and health care professional groups, to submit public comments on a proposed rule affecting Medicare Advantage and Medicare Part D. The letter emphasized the need to balance prescription drug plan flexibility with protections for Medicare enrollees. Read the letter here.

Older News by Year